Oxidative stress involvement in chemically induced differentiation of K562 cells

Free Radical Biology and Medicine

Volumn 28, Issue 1, 2000, Pages 18-27

  Chénais, Benoît ^a   Andriollo, Maud ^b   Guiraud, Pascale ^b   Belhoussine, Rajae ^c   Jeannesson, Pierre ^a  

^a Lab Biochim Med de Biol Molec   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c Faculte de Pharmacie   (France)

Author keywords

Aclarubicin; Antioxidants; Butyric acid; Doxorubicin; Free radicals; Hemin; K562 cells; Oxidative stress; Tumor cell differentiation

Indexed keywords

ACETYLCYSTEINE; ACLARUBICIN; ANTIOXIDANT; BUTYRIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DOXORUBICIN; FREE RADICAL; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMIN; PYRROLIDINE DITHIOCARBAMATE; QUERCETIN; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR CELL;

ACLARUBICIN; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLOOD PROTEINS; BUTYRIC ACID; CATALASE; CELL DIFFERENTIATION; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMIN; HUMANS; K562 CELLS; LIPID PEROXIDATION; NEOPLASM PROTEINS; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; QUERCETIN; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSCRIPTION FACTORS;

EID: 2542507664     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00195-1     Document Type: Article

References (50)

1. Beere H.M., Hickman J.A. Differentiation a suitable strategy for cancer chemotherapy? Anticancer Drug Des. 8:1993;299-322.
2. Fenaux P., Chastang C., Chomiennne C., Degos L. Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Lancet. 343:1994;1033.
3. Reiss M., Gamba-Vitalo C., Sartorelli A.C. Induction of tumor cell differentiation as a therapeutic approach preclinical models for hematopoietic and solid neoplasms . Cancer Treat. Rep. 70:1986;201-218.
4. Degos L., Dombret H., Chomienne C., Daniel M.T., Micléa J.M., Chastang C., Castaigne S., Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood. 85:1995;2643-2653.
5. Newmark H.L., Young C.W. Butyrate and phenylacetate as differentiating agents practical problems and opportunities . J. Cell. Biochem. Suppl. 22:1995;247-253.
6. Jeannesson P., Lahlil R., Chénais B., Devy L., Gillet R., Aries A., Morceau F., Trentesaux C. Anthracyclines as tumor cell differentiating agents effects on the regulation of erythroid gene expression . Leuk. Lymphoma. 26:1997;575-587.
7. Casazza A.M. Anthracyclines as inducers of tumor cell differentiation. Lown J.W. Bioactive molecules. 1988;715-734 Elsevier, Amsterdam.
8. Gabbay E.J., Grier D., Fingerle R.E., Reimer R., Levy R., Pearce S.W., Wilson W.D. Interaction specificity of the anthracyclines with deoxyribonucleic acid. Biochemistry. 15:1976;2062-2069.
9. Jensen P.B., Sorensen B.S., Sehested M., Demant E.J., Kjeldsen E., Friche E., Hansen H. Different modes of anthracycline interaction with topoisomerase II. Biochem. Pharmacol. 45:1993;2025-2035.
10. Bridewell D.J.A., Finlay G.J., Baguley B.C. Differential actions of aclarubicin and doxorubicin the role of topoisomerase I . Oncology Res. 9:1997;535-542.
11. Papadopoulou L.C., Tsiftsoglou A.S. Mitochondrial cytochrome c oxidase as a target site for daunomycin in K-562 cells and heart tissue. Cancer Res. 53:1993;1072-1078.
12. Doroshow J.H. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase. Cancer Res. 43:1983;4543-4551.
13. Powis G. Free radical formation by antitumor quinones. Free Radic. Biol. Med. 6:1989;63-101.
14. Keizer H.G., Pinedo H.M., Schuurhuis G.J., Joenje H. Doxorubicin (adriamycin) a critical review of free radical-dependent mechanisms of cytotoxicity . Pharmacol. Ther. 47:1990;219-231.
15. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood. 45:1975;321-334.
16. Dean A., Erard F., Schneider A.B., Schechter A.N. Induction of hemoglobin accumulation in human K562 cells by hemin is reversible. Science. 212:1981;459-461.
17. Chénais B., Molle I., Trentesaux C., Jeannesson P. Time-course of butyric acid-induced differentiation in human K562 leukemic cell line rapid increase in γ-globin, porphobilinogen deaminase and NF-E2 mRNA levels . Leukemia. 11:1997;1575-1579.
18. Chénais B. Requirement of GATA-1 and p45 NF-E2 protein expression in butyric acid-induced differentiation. Biochem. Biophys. Res. Commun. 253:1998;883-886.
19. Morceau F., Chénais B., Gillet R., Jardillier J.C., Jeannesson P., Trentesaux C. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells. Cell Growth Differ. 7:1996;1023-1029.
20. Morceau F., Aries A., Lahlil R., Devy L., Jardillier J.C., Jeannesson P., Trentesaux C. Evidence for distinct regulation processes in the aclacinomycin and doxorubicin-mediated differentiation of human erythroleukemic cells. Biochem. Pharmacol. 51:1996;839-845.
21. Aries A., Trentesaux C., Ottolenghi S., Jardillier J.C., Jeannesson P., Doubeikovski A. Activation of erythroid specific promoters during anthracycline-induced differentiation of K562 cells. Blood. 87:1996;2885-2890.
22. Nowak D., Drzewoski J. Anthracycline-induced oxidative stress-its role in the development of cardiac damage. Cancer J. 9:1996;296-303.
23. Singal P.K., Iliskovic N., Li T., Kumar D. Adriamycin cardiomyopathy pathophysiology and prevention . FASEB J. 11:1997;931-936.
24. Ngo-Nyoung M., Trentesaux C., Aries A., Carpentier Y., Jardillier J.C., Gorisse M.C., Jeannesson P. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Anticancer Res. 14:1994;1203-1208.
25. Marklund S., Marklund G. Involvement of the superoxide anion radical in the auto-oxidation of pyrogallol and a convenient assay of superoxide dismutase. Eur. J. Biochem. 47:1974;469-474.
26. Lowry D.H., Rosebrough N.J., Farra A., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Flohe L., Günzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 105:1984;114-121.
28. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 113:1985;484-490.
29. Beers B., Sizer W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195:1952;133-139.
30. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide and glutathione mixed disulfides in biological samples. Methods Enzymol. 77:1981;373-382.
31. Emonet N., Leccia M.T., Favier A., Beani J.C., Richard M.J. Thiols and selenium protective effect on human skin fibroblasts exposed to UVA radiation . J. Photochem. Photobiol. B. 40:1997;84-90.
32. Shopsis C., Mackay G.J. Semi automated assay for cell culture. Anal. Biochem. 140:1984;104-107.
33. Richard M.J., Portal B., Meo J., Coudray C., Hadjian A., Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin. Chem. 38:1992;704-709.
34. Nagy, K.; Pasti, G.; Bene, L.; Zs-Nagy, I. Induction of granulocytic maturation of HL-60 human leukemia cells by free radicals: a hypothesis of cell differentiation involving hydroxyl radicals. Free. Radic. Res. Comm. 19:1-6, 1993.
35. Nagy, K.; Pasti, G.; Bene, L.; Zs-Nagy, I. Involvement of Fenton reaction products in differentiation induction of K562 human leukemia cells. Leukemia Res. 19:203-212, 1995.
36. McCord J.M. Oxygen-derived free radicals. New Horiz. 1:1993;70-76.
37. Buechter D.D. Free radicals and oxygen toxicity. Pharm. Res. 5:1988;253-260.
38. McCord J.M. Roles of superoxide in inflammation and ischemic shock. Sorenson J.R.J. Inflammatory diseases and copper. 1982;255-266 Humana Press, Totowa, NJ.
39. Zs-Nagy I. A proposal for reconsideration of the role of oxygen free radicals in cell differentiation and aging. Ann. N.Y. Acad. Sci. 673:1992;142-150.
40. Leppä S., Pirkala L., Chow S.C., Eriksson J.E., Sistonen L. Thioredoxin is transcriptionally induced upon activation of heat shock factor 2. J. Biol. Chem. 272:1997;30400-30404.
41. Jones D.P., Maellaro E., Jiang S., Slater A.F., Orrenius S. Effects of N-acetyl-L-cysteine on T-cell apoptosis are not mediated by increased cellular glutathione. Immunol. Lett. 45:1995;205-209.
42. Giardina C., Inan M.S. Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells. Biochim. Biophys. Acta. 1401:1998;277-288.
43. Rocchi P., Ferreri A.M., Simone G., Prodi G. Epirubicin-induced differentiation of human neuroblastoma cells in vitro. Anticancer Res. 7:1987;247-250.
44. Supino R., Mariani M., Colombo A., Prosperi E., Croce A.C., Bottiroli G. Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells. Eur. J. Cancer. 28A:(Suppl.):1992;778-783.
45. Wilson R.G., Feit S., Vossugh S., Randolph V. Aclacinomycin A and adriamycin induction of differentiation of HL-60 and ML-1 cells (abstract). Proc. Am. Assoc. Cancer Res. 27:1986;749.
46. Stücker U., Schaefer A., Maquardt H. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin. Leukemia. 9:1995;146-154.
47. Sinha B.K., Trush M.A., Kennedy K.A., Minnaugh E.G. Enzymatic activation and binding of adriamycin to nuclear DNA. Cancer Res. 44:1984;2892-2896.
48. Pigeolet E., Corbisier P., Houbion A., Lambert D., Michiels C., Raes M., Zachary M.D., Remacle J. Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech. Ageing Dev. 51:1990;283-297.
49. Julicher R.H., Sterrenberg L., Bast A., Riksen R.O., Koomen J.M., Noordhoek J. The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart. J. Pharm. Pharmacol. 38:1986;277-282.
50. Sazuka Y., Tanizawa H., Takino Y. Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice. Jpn. J. Cancer Res. 80:1989;89-94.